Plasmodium Falciparum: Clinical Trials

6 trials for Plasmodium Falciparum, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 active not recruiting, 1 recruiting. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Active not recruiting 1, Recruiting 1
Phase 21Completed 1

Follow Plasmodium Falciparum: new trials by email Literature Review of Plasmodium Falciparum trials Research Report on Plasmodium Falciparum

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar
PvSeroTAT, Control - Malaria Vivax, Malaria Falciparum
Phase 3RecruitingLondon School of Hygiene and Tropical Medicine192002025-05-122026-09-18
Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia
Dihydroartemisinin-piperaquine - Plasmodium Falciparum, Malaria
Phase 3Active not recruitingPATH103502024-08-212025-05-06
Comparison of Arterolane-piperaquine Versus Arterolane-piperaquine+Mefloquine Versus Artemether-lumefantrine in Kenyan Children
Arterolane-piperaquine, Arterolane-piperaquine+mefloquine, Artemether-lumefantrine - Plasmodium Falciparum
Phase 3CompletedUniversity of Oxford2192018-03-072021-09-29
Dihydroartemisinin-piperaquine With Low Dose Primaquine to Reduce Malaria Transmission
Dihydroartemisinin-piperaquine combination (Artekin), Primaquine - Malaria, Asymptomatic Malaria
Phase 3CompletedLondon School of Hygiene and Tropical Medicine1202014-10-012016-01-14
Low Dose Primaquine for Clearance of Gametocytes
Artemether-lumefantrine combination, Artemether-Lumefantrine with a single dose of 0.25mg/kg primaquine, Artemether-Lumefantrine with a single dose of 0.4mg/kg primaquine - Malaria, Asymptomatic Malaria
Phase 2 / Phase 3CompletedLondon School of Hygiene and Tropical Medicine3602013-09-012015-09-02
Antimalarial Treatments for Clearing Low Density P. Falciparum and Its Impact on Malaria Transmission
Sulfadoxine / Pyrimethamine (SP) plus artesunate (AS), placebo tablet similar to active drug in shape and size - Plasmodium Falciparum, Asymptomatic Parataemia
Phase 3CompletedTropical Medicine Research Institute2005-08-012008-03-28

Narrower conditions

Malaria, Falciparum (6)  ·  Malaria (3)  ·  Malaria, Vivax (1)

Broader conditions

Infections (6)  ·  Mosquito-Borne Diseases (6)  ·  Parasitic Diseases (6)  ·  Protozoan Infections (6)  ·  Vector Borne Diseases (6)  ·  Malaria (3)

Interventions

Artemether, Lumefantrine Drug Combination (2)  ·  Primaquine (2)  ·  Pyrimethamine (1)  ·  Sulfadoxine (1)  ·  artenimol (1)  ·  piperaquine (1)

Sponsors

London School of Hygiene and Tropical Medicine (3)  ·  PATH (1)  ·  Tropical Medicine Research Institute (1)  ·  University of Oxford (1)

Countries

Ethiopia (2)  ·  Kenya (2)  ·  Burkina Faso (1)  ·  Madagascar (1)  ·  Sudan (1)

Top investigators

Adam Bennett, PhD (1)  ·  Alfred Tiono, PhD, MD (1)  ·  Badria B El Sayed, PhD,MSc,BSc (1)  ·  Chris Drakeley (1)  ·  Fitsum G Tadesse (1)  ·  Gudissa Assefa Bayissa (1)  ·  Henry Ntuku, MD, PhD (1)  ·  Hiwot Teka (1)  ·  Michael T White (1)  ·  Patrick Sawa, MD (1)  ·  Rindra Randremanana (1)  ·  Teun Bousema, PhD (1)

Results publications

PMID 26952094, PMID 28289025, PMID 34111412, PMID 34585740